Stockholm - Delayed Quote SEK

Vivesto AB (VIVE.ST)

0.2285
+0.0015
+(0.66%)
At close: June 13 at 5:23:07 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
1,015
26,192
Cost of Revenue
--
--
0
11,671
44,122
Gross Profit
--
--
0
-10,656
-17,930
Operating Expense
41,371
41,962
138,808
347,066
113,590
Operating Income
-41,371
-41,962
-138,808
-357,722
-131,520
Net Non Operating Interest Income Expense
-506
0
5
-19
-5,136
Pretax Income
-39,621
-39,754
-128,740
-356,612
-132,722
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-39,621
-39,754
-128,740
-356,612
-132,722
Diluted NI Available to Com Stockholders
-39,621
-39,754
-128,740
-356,612
-132,722
Basic EPS
-0.07
-0.07
-0.24
-0.72
-0.30
Diluted EPS
-0.07
-0.07
-0.24
-0.72
-0.30
Basic Average Shares
538,043
538,043
538,043
493,207
448,370
Diluted Average Shares
538,043
538,043
538,043
493,207
448,370
Total Operating Income as Reported
-41,371
-41,962
-132,171
-355,397
-128,647
Total Expenses
41,371
41,962
138,808
358,737
157,712
Net Income from Continuing & Discontinued Operation
-39,621
-39,754
-128,740
-356,612
-132,722
Normalized Income
-41,778
-41,911
-132,973
-355,301
-132,802
Interest Income
-503
3
5
20
1,167
Interest Expense
--
3
0
39
6,303
Net Interest Income
-506
0
5
-19
-5,136
EBIT
-39,160
-39,751
-128,740
-356,573
-126,419
EBITDA
-34,247
-34,838
-71,366
-104,279
-97,542
Reconciled Cost of Revenue
--
--
0
11,671
44,122
Reconciled Depreciation
4,913
4,913
57,374
252,294
28,877
Net Income from Continuing Operation Net Minority Interest
-39,621
-39,754
-128,740
-356,612
-132,722
Total Unusual Items Excluding Goodwill
2,157
2,157
4,233
-1,311
80
Total Unusual Items
2,157
2,157
4,233
-1,311
80
Normalized EBITDA
-36,404
-36,995
-75,599
-102,968
-97,622
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/24/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ENZY.ST Enzymatica AB (publ)
3.0300
0.00%
 
ZYBT Zhengye Biotechnology Holding Limited
6.34
-13.03%
 
SXTC China SXT Pharmaceuticals, Inc.
1.8300
-10.29%
 
PTPI Petros Pharmaceuticals, Inc.
0.0310
-8.82%
 
IXHL Incannex Healthcare Inc.
0.2062
-11.73%
 
GELS Gelteq Limited
2.1000
-8.70%